EYES Second Sight Medical Products
$29.27
Second Sight Medical Products (EYES) Institutional Ownership
What the institutions did with EYES last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to.
No institutional holdings on record for EYES.